Merck & Co., Inc. Share Sell-Off by Sarasin & Partners LLP
Sarasin & Partners LLP has adjusted its investment portfolio in Merck & Co., Inc. (NYSE:MRK) by selling 49,029 shares during the second quarter.
This change represents a 6.2% reduction in their holdings, leaving them with 736,662 shares of MRK's stock.
The value of these holdings is approximately $94.66 million at the end of the most recent reporting period.